Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Mesoblast

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Mesoblast

Regulatory records
1
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 1 FDA record to the applicant name Mesoblast. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 23, 2025 to Dec 23, 2025. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MOZ appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P170016, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: Level 38, 55 Collins St., Melbourne, 3000. Recorded on P170016/S001, decision dated Dec 23, 2025.

Changes described in PMA records

P170016/S001: SYNOJOYNT

FDA’s recorded scope: Approval for the replacement and relocation of the blistering and labeling equipment and minor change to process and size of label.

Dec 23, 2025 · 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

  1. SYNOJOYNT

    P170016/S001 · PMA supplement
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.